Review on the Role of Epigenetic Modifications in Doxorubicin-Induced Cardiotoxicity

Use of anthracyclines such as doxorubicin (DOX), for the treatment of cancer, is known to induce cardiotoxicity, begetting numerous evaluations of this adverse effect. This review emphasizes the mechanism of how consideration of DOX-induced cardiotoxicity is important for the development of cardiopr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumari, Himani, Huang, Wan-Hong, Chan, Michael W. Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221144/
https://www.ncbi.nlm.nih.gov/pubmed/32457918
http://dx.doi.org/10.3389/fcvm.2020.00056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7221144/
https://www.ncbi.nlm.nih.gov/pubmed/32457918
http://dx.doi.org/10.3389/fcvm.2020.00056

Ejemplares similares